The Medicines Company (MDCO) reported first quarter earnings of 24 cents per share, compared with the year-ago earnings of 14 cents per share.
Including one-time items, the...(read more
The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase III candidate, cangrelor. Cangrelor is being...(read more
My morning pick is The Medicines Company MDCO from the Biomedical Sector.
How does this company make money?
The Medicines Company is focused on advancing the treatment of critical care patients...(read more